Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 800 results for "genentech"

Andy Skibo Of MedImmune/AstraZeneca Will Be A Featured Panelist For Outsourced Pharma West Conference
Pharmaceutical Online

Genentech to Speak at Pharmica Consulting's West Coast SharePo...

PRWeb As part of its continued service to the industry, Pharmica will host its 11th SharePoint conference in San Diego, CA on September 30 and October 1, 2014. The two-day conference will highlight real-world case studies and feature interactive ... Financial Content, 16 hours ago

66 images for genentech

Pharmafocus, 1 week ago
Southtown Star, 1 week ago
Drug Discovery and Development, 1 week ago
KXXV-TV, 5 days ago, 1 week ago
Xconomy, 1 week ago
New Indian Express, 1 week ago, 1 week ago
Drug Discovery and Development, 2 weeks ago
San Francisco Business Times, 2 weeks ago

Omalizumab Effective for Chronic Hives up to 24 Weeks

Omalizumab ( Xolair , Genentech Inc and Novartis Pharmaceuticals Corporation) is effective at controlling chronic hives for up to 24 weeks, according to results of a clinical trial by Sarbjit S. Saini, MD, from the Johns Hopkins Asthma and Allergy ...
 American Journal of Public Health1 day ago Asthma drug relieves chronic hives  Dermatology Times6 days ago Asthma Drug May Help Those With Chronic Hives  US News & World Report1 week ago

Genentech's ovarian cancer drug receives FDA acceptance for priority review

Genentech Inc., a biotechnology company, has announced the FDA acceptance and priority review for the company's supplemental biologics license application, or sBLA, of Avastin plus chemotherapy for the treatment of women with persistent, recurrent ...
 Individual.com4 days ago Genentech's cervical cancer drug receives FDA acceptance for priority review  Individual.com1 week ago

Crenezumab Fails in Alzheimer's but Is There a Silver Lining?

COPENHAGEN, Denmark ― In 2 phase 2 clinical trials on the investigational drug crenezumab (Genentech), the drug failed to slow cognitive decline or improve global functioning in patients with mild to moderate Alzheimer's disease (AD) ― ...
 Medscape4 days ago Mixed bag for Genentech dementia drug  Pharmafocus1 week ago Mixed results for Genentech Alzheimer's drug  San Francisco Chronicle1 week ago Genentech's Alzheimer's drug has mixed results in trials  San Francisco Chronicle1 week ago

Genentech Reports FDA Priority Review for Avastin

Genentech reported that the U.S. Food and Drug Administration has accepted the company's supplemental Biologics License Application and granted Priority Review for Avastin (bevacizumab) plus chemotherapy for the treatment of women with recurrent ...
 Individual.com4 days ago FDA accepts sBLA, grants priority review for Genentech's cervical cancer therapy Avastin plus  Pharmaceutical Business Review1 week ago

Priority review for Avastin

The FDA accepts Genentech's ( OTCQX:RHHBY ) sBLA for Avastin ( bevacizumab ) plus chemotherapy for the treatment of women with recurrent platinum-resistant ovarian cancer and designates it for Priority Review. The Priority Review tag is granted to ...
 Seeking Alpha1 week ago Priority Review For Genentech's Avastin  American Journal of Managed Care1 week ago FDA Grants Genentech's Avastin Priority Review for Recurrent Platinum-Resistant Ovarian Cancer  Town Hall1 week ago FDA Grants Genentechs Avastin Priority Review for Recurrent Platinum-resistant Ovarian Cancer  Newswire Today1 week ago

Melanoma combination therapy study shows promising results

Genentech has announced that its phase 3 coBRIM study, evaluating the safety and efficacy of a combination of cobimetinib and vemurafenib for the treatment of melanoma, has met its primary endpoint. Genentech, a Roche company, studied the ...
 Dermatology Times6 days ago Genentech's Phase III melanoma study meets primary endpoint  Individual.com1 week ago
Jutia Group

Over Half of Audited Multiple Sclerosis Patients Currently Treated with Biogen Idec's Tecfidera Have Experienced Minor Side Effects Although Impact on Use Appears Muted

Genzyme/Sanofi's Lemtrada and Genentech/Roche's Ocrelizumab Will Likely Be Reserved for Patients with Aggressive/Severe MS, According to Findings from Decision Resources Group BURLINGTON, Mass., July 22, 2014 /PRNewswire/ — Decision Resources ...
 Red Orbit6 days ago Can Biogen Idec Take Wing With Tecfidera?  Seeking Alpha9 hours ago Biogen Idec Beats And Raises: Reassessing Its Prospects  Seeking Alpha6 days ago Market Update (NASDAQ:BIIB): Biogen Idec Second Quarter 2014 Revenues Increase 40% to $2.4 Billion; Company Raises Financial Guidance for the Year  Jutia Group6 days ago
New Indian Express

Genentech Alzheimer's drug misses goals in studies

Researchers say an experimental drug from the biotech company Genentech failed to slow mental decline in tests on more than 500 people with mild to moderate Alzheimer's disease. The drug did show some promise in the least-impaired participants who ...
 Town Hall1 week ago Genentech Alzheimer's drug misses study goals but shows some promise in milder disease  Huffington Post Canada1 week ago Genentech Alzheimers drug misses goals in studies  Big News Network1 week ago Genentech Alzheimers drug misses study goals but shows some promise in milder disease  Big News Network1 week ago

Genomics startup allies with Illumina

Herbert Boyer, a cofounder of Genentech; Henry Nordhoff, former chief executive of Gen-Probe; and Andrew von Eschenbach, a former commissioner of the U.S. Food and Drug Administration, have
 Big News Network4 days ago Cypher Genomics Signs Deal with Illumina, Expands Executive Team  Bio-IT World4 days ago Cypher Genomics Appoints to the Board of Directors, Henry Nordhoff as Executive Chairman and Herbert Boyer and Andrew Von Eschenbach as Directors  TickerTech.com5 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less